Corruption Category Regulation
Anti-corruption work relating to the regulation of the healthcare sector. Corruption in healthcare regulation is a serious issue and recognised as such – failures or breaches of regulation put patients in danger.
Transparency and accountability in public administration and service
Research using data from ProZorro showed that there is considerable monopolization on procurement in the health sector. ProZorro is a fully online public procurement platform and a collaboration environment that ensures open access to public procurement (tenders) in Ukraine.
Governance of the Directorate of Drug Administration: Challenges and Way forward
The study assessed the effectiveness of the Government Drug Administration to tackle corruption. The study follows recent measures by the Government to strengthen the capacities of the Drug Administration. These include increasing the workforce in field offices, investing in capacity building, and enhancing the central drug laboratory. Moreover, the Government Drug Administration has taken measures…
Promoting transparency in the health sector
The main aim is to create a better understanding between doctors and patients in order to enhance the quality of service delivery in healthcare clinics.
Supporting the implementation of drug control policies
The main objective of this project is to promote public health through the prevention and fight against illegal drugs, alcohol abuse and tobacco consumption in communities. It aims to create anti drugs coalitions in community-based to inform, educate sensitize adolescents and young people about disorders related to the use of psychoactive substances.Till now we count 7 coalitions in Lome .
Action For Transparency
The project is aimed at empowering citizens to monitor public resources in the health sector and report on any misappropriation through ICT platforms including a mobile application and website.
A base line survey conducted in Nairobi County Embakasi sub-county showed gaps in capacity of health facility management committees on budget management and monitoring while an analysis of the Auditor General reports shows wastage of resources that should be spent to improve public services.
The project works with stakeholders in the health sector including but not limited to HFMCs ,facility in charges, citizens ,CSOs, government agencies and government .
Increasing Participation, Accountability, Responsiveness and Transparency (PART): focus on the National Health Insurance Scheme (NHIS) and other MDG-related interventions in the health sector in Ghana’
To achieve improved transparency and accountability in the flow and utilisation of NHIS financial resources leading to improved health service delivery in selected deprived districts by December 2014. The original project was focused on three regions and was financially supported by STAR-Ghana, a multi-donor agency.
Transparency Tools for the Private Sector: Promoting Tools to Improve Transparency Standards in the Pharmaceutical Sector – Multi-Sectorial Transparency Agreement
To promote transparency in the pharmaceutical sector.
i) to provide a space for knowledge sharing and networking, with a view of setting up an agenda for multi-stakeholder collaboration and increase transparency in the pharmaceutical sector;
ii) to establish a guide outlining principles to strengthen transparency in the sector, which would support the signing of multi-stakeholder transparency agreements (MTA);
iii) to promote synergies among all relevant actors within the pharmaceutical sector
Improve Transparency and Accountability in Health Sector under Building Integrity Blocks for Effective Change (BIBEC) Project
The overall objective of BIBEC is to concentrate on building and strengthening a series of mutually supportive and reinforcing integrity blocks to effectively reduce corruption. “Blocks” here imply the key institutions, policy/law, education, training, ethics and values, and above all, the people of the country.
Transparency International Bangladesh's work on health issues mainly includes research and advocacy at local and national levels. The main objective of these activities is to bring about positive changes in policies and practices of concerned authorities in regard to ensuring good governance and integrity in health services.
Global Partners:GlaxoSmithKline Plc. World Health Organisation (WHO) FOJO Department for International Development UK (DIFD) Swedish International Development Cooperation Agency (SIDA)
Hospital Health Management Committees
Ministry of Health
NGO or Civil Society Organisation
Lithuanian Young Doctors Association
The Cancer Patients Support Association (POLA)
Individuals or general public